Jul 5, 2026
Tulkpharma commissions new WHO-GMP production line
A €12M investment expands capacity for solid-dose manufacturing.
Jun 23, 2026
Cardiovita approved in three new markets
Regulatory clearance extends access for hypertension patients.
May 29, 2026
Tulkpharma partners with university hospitals on research
A new collaboration accelerates clinical studies across the region.